TOKYO, Oct. 4, 2024 /PRNewswire/ -- "Pell BMT Ltd.", a pioneering force in CAR-T (Chimeric Antigen Receptor T Cells) cell therapies in Taiwan, will attend the prestigious BioJapan 2024 exhibition in Yokohama (October 9-11). This biotechnology exposition, established in 1986, has become a platform for innovation and collaboration within the global biotechnology industry.

Register to unlock this article

Register to read this story and more for free.

Signing up for an account helps us improve your browsing experience.

Continue

OR

See our subscription options.

Already have an account? Log in here